MGC Pharmaceuticals to sponsor first medical cannabis conference in London
Australian-based medical grade cannabis company, MGC Pharmaceuticals, will sponsor and speak at the first conference on medical cannabis in the UK — CannaTech UK Innovation Summit.
“We are extremely happy to be sponsoring CannaTech UK. As one of the world’s leading medical grade Cannabis companies working to improve global health, MGC Pharma sees CannaTech UK as a key venue for reaching the European market, which is poised to grow exponentially, reaching billions of dollars in the next decade,” said Roby Zomer, CEO & executive director of MGC Pharma. “We hope that MGC’s speakers will contribute much to both the scientific and financial discourse at the event.”
CannaTech UK will take place on 26 October at The Old Truman Brewery. There will also be a pre-event investor symposium on 25 October that will be focused on ins-and-outs of investing in the medical cannabis industry.
During the event, Dr Neubauer and Ron Lipsky from MGC Pharmaceuticals will be speaking on their respective experiences in the field — Neubauer has recently conducted a clinical study to assess the efficacy of a medical cannabis formulation in children with treatment-resistant epilepsy and Ron Lipsky is the manager of business development and international relations at MGC Pharma and has been working for over 10 years in the medical cannabis industry, primarily in Israel.
